Epilepsies, Partial: all 255 studies

Page 1 of 3. Open to participants first (48), then studies with results posted, then the rest; newest registration first within each.

• RNS System for Drug-Resistant Focal Epilepsy in Adolescents: A Real-World StudyEnrolling by invitationNCT07823465
• Prospective Study of Eslicarbazepine in Adults With Focal-Onset SeizuresRecruitingNCT07793396
• Prognosis of Epilepsy With Post-traumatic Stress Disorder and SurgeryNot yet recruitingNCT07718542
• Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant EpilepsyRecruitingNCT07680842Not applicable
• High-density Flexible μECoG for Epilepsy Surgery - A Single-Arm ECTRecruitingNCT07656857Not applicable
• A Study to Evaluate the Safety, Efficacy, and PK of ONO-2017 in Japanese Patients With POS 2 to 17 Year OldsRecruitingNCT07594158Phase 3
• Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal SeizuresRecruitingNCT07594119Phase 3
• Spatial Scene Recognition Memory in Epilepsy SurgeryRecruitingNCT07580183Not applicable
• Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1RecruitingNCT07563881Phase 3
• Efficacy of Probenecid on Cluster Seizures During Anti Seizure Medication Withdrawal in Presurgical Focal Epilepsy Video-EEG MonitoringRecruitingNCT07318870Phase 2
• An Open-label Study to Evaluate Safety, Tolerability, and Efficacy of CB03-154 in Subjects Diagnosed With EpilepsyRecruitingNCT07238868Phase 2
• A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset SeizuresRecruitingNCT07219407Phase 2
• Butylphthalide for Cognitive Impairment in Elderly Patients With Focal EpilepsyRecruitingNCT07193277Phase 4
• SPN-817 Open-Label Extension Study in Adults With Focal Onset SeizuresRecruitingNCT07141329Phase 2
• Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and WearablesRecruitingNCT07012148Early Phase 1
• A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic SeizuresRecruitingNCT06967012Phase 4
• Home Ultra-long Term EEG Monitoring for Rare Epilepsies and Developmental and Epileptic EncephalopathiesRecruitingNCT06855901Not applicable
• RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset SeizuresRecruitingNCT06798896Phase 2
• Extreme Capsule Electrical Stimulation for Drug-resistant Focal EpilepsyNot yet recruitingNCT06663124Not applicable
• A Study to Evaluate the Safety, Tolerability, and Efficacy of CB03-154 in Adult Patients With Focal EpilepsyRecruitingNCT06612775Phase 2
• The Mosaic Brain: a New Diagnostic Approach in Focal EpilepsiesNot yet recruitingNCT06602570
• Safety of Cenobamate in Japanese Subjects With Partial Onset SeizuresRecruitingNCT06590896Phase 2
• High-resolution Multi-parametric Magnetic Resonance Imaging for Focal EpilepsyRecruitingNCT06550726Not applicable
• Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset SeizuresNot yet recruitingNCT06534502Phase 4
• Changes in Attentional Control After a Focal Seizure.RecruitingNCT06466681
• Thalamic Recordings in Children Undergoing SEEGRecruitingNCT06453759Not applicable
• Long-term Safety and Tolerability of BHV-7000Enrolling by invitationNCT06443463Phase 2
• Real-world Study of Efficacy and Safety of Zonisamide in add-on Therapy for Patients With Focal EpilepsyNot yet recruitingNCT06374966
• Assessment of Patients With Drug-resistant Temporal Lobe Epilepsy With EEG Extended With Intra-auricular ElectrodesNot yet recruitingNCT06366009
• Cognitive Impairment in Drug-resistant and Drug-responsive Focal Cryptogenic EpilepsyRecruitingNCT06210022
• Evaluation of New Flexible High-density Intra-operative ECoG Electrodes for Epilepsy Surgery. ( EpiGrid )RecruitingNCT06205160Not applicable
• Breathing Rescue for SUDEP PreventionRecruitingNCT05981755Not applicable
• Induced Pluripotent Stem Cell Derived Exosomes Nasal Drops for the Treatment of Refractory Focal EpilepsyRecruitingNCT05886205Early Phase 1
• Electrical Neuromodulation for Focal EpilepsyNot yet recruitingNCT05844696Phase 1/2
• Sleep Architecture & Cognition in Focal EpilepsyRecruitingNCT05794295Not applicable
• The Efficacy and Safety of Lamotrigine Versus Carbamazepine in Focal EpilepsyEnrolling by invitationNCT05748236Phase 4
• An Open-label Study of XEN1101 in EpilepsyEnrolling by invitationNCT05718817Phase 3
• Study of Transcranial Direct Current Stimulation to Treat EpilepsyRecruitingNCT05673915Not applicable
• Electroclinical Correlation of AnxietyRecruitingNCT05393518Not applicable
• Optimized Volumetry in Radiology: Interest in Pediatric Brain MRI in the Exploration of Focal EpilepsyRecruitingNCT05100771
• Diffusion MRI Methods to Minimize Postoperative Deficits in Pediatric Epilepsy SurgeryRecruitingNCT04986683Not applicable
• Multi-level Approach of Brain Activity Using Intracranial Electrodes in Epileptic PatientsRecruitingNCT04653012Not applicable
• Treating Postictal Symptoms Using Ibuprofen and NifedipineRecruitingNCT03949478Phase 2
• Atlas of Human Cognition by SEEG (MAPCOG-SEEG)RecruitingNCT03644732
• Investigating Epilepsy: Screening and EvaluationRecruitingNCT03478852
• Impact of Epileptic Discharge on the Structural Connectivity of the Developing BrainRecruitingNCT03268824
• Genetic and Electrophysiologic Study in Focal Drug-resistant EpilepsiesRecruitingNCT02890641
• Surgery as a Treatment for Medically Intractable EpilepsyRecruitingNCT01273129
• An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset SeizuresTerminatedNCT04686786Phase 2Results posted
• Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal EpilepsyTerminatedNCT04650204Phase 4Results posted
• A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal EpilepsyActive, not recruitingNCT03796962Phase 2Results posted
• Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW)CompletedNCT03689114Phase 4Results posted
• Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal EpilepsyCompletedNCT03283371Phase 2Results posted
• EEG Cap for Identification of Non-Convulsive Status EpilepticusCompletedNCT03138876Not applicableResults posted
• An Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal EpilepsyTerminatedNCT02625090Phase 2Results posted
• Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset SeizuresCompletedNCT02535091Phase 3Results posted
• A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal EpilepsyCompletedNCT02495844Phase 2Results posted
• Cognitive AED Outcomes in Pediatric Localization Related Epilepsy (COPE)TerminatedNCT01891890Phase 3Results posted
• A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset SeizuresCompletedNCT01866111Phase 2Results posted
• Arterial Spin Labeling MRI Focal Abnormalities in Refractory EpilepsyCompletedNCT01772654Not applicableResults posted
• Treatment of Difficult to Control Focal Epilepsy With Repetitive Transcranial Magnetic Stimulation (rTMS)CompletedNCT01745952Not applicableResults posted
• Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination TherapyCompletedNCT01673282Results posted
• IVIG Treatment for Refractory Immune-Related Adult EpilepsyTerminatedNCT01545518Phase 2Results posted
• Effects of Eslicarbazepine Acetate (Esl, Bia 2-093) on Cognitive Function in Children With Partial Onset SeizuresCompletedNCT01527513Phase 2Results posted
• Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial EpilepsyCompletedNCT01498822Phase 4Results posted
• Buspirone Therapy for Localized EpilepsyTerminatedNCT01496612Phase 2Results posted
• A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic SeizuresCompletedNCT01463306Phase 3Results posted
• Safety and Efficacy of Gabapen for Pediatric (Regulatory Post Marketing Commitment Plan)CompletedNCT01441401Results posted
• Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset SeizuresCompletedNCT01397968Phase 2Results posted
• A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 YearsCompletedNCT01389596Phase 3Results posted
• Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to LacosamideTerminatedNCT01375374Phase 3Results posted
• PRX-00023 Therapy in Localization-Related EpilepsyTerminatedNCT01281956Phase 2Results posted
• Once-A-Day Pregabalin For Partial SeizuresCompletedNCT01262677Phase 3Results posted
• Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset SeizureCompletedNCT01235403Phase 4Results posted
• Randomized Controlled Trial to Assess Effects of Lacosamide on Sleep and Wake in Adults With Focal EpilepsyCompletedNCT01190098Phase 4Results posted
• Open-label, Multi-center Trial of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial EpilepsyCompletedNCT01140867Phase 4Results posted
• Vimpat® Added as Adjunctive Therapy to One Baseline Antiepileptic DrugCompletedNCT01098162Results posted
• Safety & Efficacy of Eslicarbazepine Monotherapy in Sub.w/Partial Epilepsy Not Well Controlled by Current AntiepilepticCompletedNCT01091662Phase 3Results posted
• Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial SeizuresCompletedNCT00988429Phase 3Results posted
• Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in ChildrenCompletedNCT00988156Phase 3Results posted
• Efficacy of Fluoxetine in Reducing Ictal Hypoventilation in Patients With Partial EpilepsyCompletedNCT00986310Not applicableResults posted
• Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial SeizuresCompletedNCT00957684Phase 3Results posted
• Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial EpilepsyCompletedNCT00957372Phase 3Results posted
• Efficacy and Safety Study of BIA 2-093 in Combination With Other Anti-Epileptic Drugs to Treat Partial EpilepsyCompletedNCT00957047Phase 3Results posted
• Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset SeizuresCompletedNCT00955357Phase 4Results posted
• Safety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial EpilepsyCompletedNCT00908349Phase 3Results posted
• Study to Evaluate Pharmacokinetics and Tolerability of Multiple Doses of Eslicarbazepine Acetate and OxcarbazepineCompletedNCT00900237Phase 1Results posted
• Effect of Repeat Administration of Eslicarbazepine Acetate on the Pharmacokinetics of a Combined Oral ContraceptiveCompletedNCT00898560Phase 1Results posted
• Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic DrugsCompletedNCT00866775Phase 3Results posted
• A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical PracticeCompletedNCT00855738Phase 4Results posted
• Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial SeizuresCompletedNCT00772603Phase 3Results posted
• Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset SeizuresCompletedNCT00771927Results posted
• Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset SeizuresCompletedNCT00655551Phase 3Results posted
• Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset SeizuresCompletedNCT00655486Phase 3Results posted
• A Phase III Open-Label Extension Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial SeizuresCompletedNCT00620555Phase 3Results posted
• A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial SeizuresCompletedNCT00603473Phase 3Results posted
• Drug Use Investigation Of GabapentinCompletedNCT00567268Results posted
• To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial SeizuresCompletedNCT00552305Phase 2Results posted
• Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial SeizuresCompletedNCT00537940Phase 4Results posted
• Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial SeizuresTerminatedNCT00524030Phase 3Results posted

← Epilepsies, Partial overview